# Eplerenone in Heart Failure Treatment

> **NCT02344199** · — · COMPLETED · sponsor: **Elpen Pharmaceutical Co. Inc.** · enrollment: 450 (actual)

## Conditions studied

- Heart Failure
- Acute Myocardial Infarction
- Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02344199
- **Lead sponsor:** Elpen Pharmaceutical Co. Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2016-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02344199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02344199, "Eplerenone in Heart Failure Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02344199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*